Early administration of surfactant via a thin intratracheal catheter in preterm infants with respiratory distress syndrome: Feasibility and outcome
Open Access
- 1 January 2015
- journal article
- research article
- Published by Medknow in Journal of Research in Pharmacy Practice
- Vol. 4 (1) , 31-6
Abstract
Objective: Currently, the method of early nasal continuous positive airway pressure (nCPAP) and selective administration of surfactant via an endotracheal tube is widely used in the treatment of respiratory distress syndrome (RDS) in premature infants. To prevent complications related to endotracheal intubation and even a brief period of mechanical ventilation, in this study, we compared the effectiveness of surfactant administration via a thin intratracheal catheter versus the current method using an endotracheal tube. Methods: Thirty eight preterm infants ≤34 weeks' gestation with birth weight of 1000-1800 g who were putted on nCPAP for RDS within the first hour of life, were randomly assigned to receive surfactant either via endotracheal tube (ET group) or via thin intratracheal catheter (CATH group). The primary outcomes were the need for mechanical ventilation and duration of oxygen therapy. Data were analyzed by independent t-test, Mann-Whitney U-test, and Chi-square test, using SPSS v. 21. Findings: There was no significant difference between groups regarding to need for mechanical ventilation during the first 72 h of birth (3 [15.8%] in ET group vs. 2 [10.5%] in CATH group; P = 0.99). Duration of oxygen therapy in CATH group was significantly lower than ET group (243.7 ± 74.3 h vs. 476.8 ± 106.8 h, respectively; P = 0.018). The incidence of adverse events during all times of surfactant administration was not statistically significant between groups (P = 0.14), but the number of infants who experienced adverse events during surfactant administration was significantly lower in CATH group than ET group (6 [31.6%] vs. 12 [63.2%], respectively; P = 0.049). All other outcomes, including duration of treatment with CPAP and mechanical ventilation, times of surfactant administration and the need for more than one dose of the drug, the rate of intraventricular hemorrhage, mortality and combined outcome of chronic lung disease or mortality were statistically similar between the groups Conclusion: Surfactant administration via thin intratracheal catheter in preterm infants receiving nCPAP for treatment of RDS has similar efficacy, feasibility and safety to its administration via endotracheal tube.Keywords
This publication has 15 references indexed in Scilit:
- Administration of Rescue Surfactant by Laryngeal Mask Airway: Lessons from a Pilot TrialAmerican Journal of Perinatology, 2012
- Pharyngeal instillation of surfactant before the first breath for prevention of morbidity and mortality in preterm infants at risk of respiratory distress syndromeCochrane Database of Systematic Reviews, 2011
- Exogenous surfactant: intubated present, nebulized future?World Journal of Pediatrics, 2010
- Early CPAP versus Surfactant in Extremely Preterm InfantsNew England Journal of Medicine, 2010
- Surfactant without Intubation in Preterm Infants with Respiratory Distress: First Multi-center DataKlinische Padiatrie, 2010
- Early surfactant in spontaneously breathing with nCPAP in ELBW infants – a single centre four year experienceActa Paediatrica, 2008
- Nasal CPAP or Intubation at Birth for Very Preterm InfantsNew England Journal of Medicine, 2008
- Surfactant Replacement TherapyChest, 2007
- Early administration of surfactant in spontaneous breathing with nCPAP: feasibility and outcome in extremely premature infants (postmenstrual age ≤27 weeks)Pediatric Anesthesia, 2006
- Technique for Intrapartum Administration of Surfactant without Requirement for an Endotracheal TubeJournal of Perinatology, 2004